Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rahul Reddy

Retina Specialist Phoenix, AZ Medical Doctor

NPI 1083806863 CMS profile 321143

1750 E Glendale Ave, Phoenix, AZ 85020

Open in the dashboard

General payments

$332,753

229 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$421,646

6 holdings reported · through program year 2025

Research they led as principal investigator

$248,071 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Rahul Reddy of Phoenix, AZ is reported in the CMS Open Payments database as having received $332,753 across 229 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $248,071 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $421,646 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Retina Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,064 4
2024 General $62,786 5
2023 General $12,547 4
2022 General $41,899 16
2021 General $52,901 33
2020 General $61,329 45
2019 General $82,227 122
2024 Ownership $69,774 1
2023 Ownership $119,774 1
2022 Ownership $58,025 1
2021 Ownership $58,025 1
2020 Ownership $58,025 1
2019 Ownership $58,025 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rahul Reddy
  • Retina Specialist median
  • Middle half of Retina Specialist
  • National median

In program year 2025, general payments to Rahul Reddy were reported at $19,064. Among 1,235 Retina Specialist profiles paid that year, the median was $457 and the middle half received between $175 and $1,079.

Show as a table
Year Rahul Reddy Retina Specialist median Middle half National median
2019 $82,227 $410 $157–$1,517 $163
2020 $61,329 $168 $65–$778 $114
2021 $52,901 $258 $101–$1,161 $132
2022 $41,899 $418 $162–$1,488 $149
2023 $12,547 $476 $178–$1,312 $160
2024 $62,786 $520 $188–$1,372 $164
2025 $19,064 $457 $175–$1,079 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. US Retina LLC $82,547 8 payments
  2. Bausch & Lomb Americas Inc. $55,058 16 payments
  3. Regeneron Healthcare Solutions, Inc. $44,097 32 payments
  4. Novartis Pharmaceuticals Corporation $40,220 45 payments
  5. Bausch & Lomb, a division of Bausch Health US, LLC $35,620 35 payments
  6. EyePoint Pharmaceuticals US, Inc. $35,134 27 payments
  7. Allergan Inc. $23,796 35 payments
  8. Alimera Sciences, Inc. $10,172 14 payments
  9. AbbVie, Inc. $5,160 3 payments
  10. Carl Zeiss Meditec, Inc. $297 4 payments
  11. Other $652 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125,098 34 payments
  2. Royalty or License $66,895 19 payments
  3. Acquisitions $50,000 1 payment
  4. Current or prospective ownership or investment interest $32,383 6 payments
  5. Consulting Fee $17,648 7 payments
  6. Travel and Lodging $14,621 29 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $9,750 2 payments
  8. Honoraria $9,250 4 payments
  9. Food and Beverage $6,991 124 payments
  10. Education $98 2 payments
  11. Other $19 1 payment
Products named General payments · program years 2019–2025
  1. OPHTHALMIC INSTRUMENTS $88,099 45 payments
  2. EYLEA $44,097 32 payments
  3. YUTIQ $34,768 24 payments
  4. OZURDEX $28,757 36 payments
  5. STELLARIS PC $19,598 23 payments
  6. BEOVU $16,053 18 payments
  7. VITESSE $11,552 18 payments
  8. ILUVIEN $10,172 14 payments
  9. LIGHT PIPES $9,959 15 payments
  10. DEXYCU $438 4 payments
  11. Other $644 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

229 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Retina Specialist in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record